Table 2.
Tumor Growth Studies
METHODS | RESULTS | ||||||
---|---|---|---|---|---|---|---|
Study | Reference | Rodent Model | Tumor Type / Induction model |
Exercise Protocol | Tumor Progression Results | ||
Exercise Modality | Exercise Prescription Freq/week | Dur | Intens | Length |
Exercise Initiation | |||||
Daneryd, 1995 | 51 | Female Wistar Furth rats |
Leydig cell / 1.5mm3 injection of Leydig cell sarcoma (LTW) |
Voluntary wheel running |
13d | Immediately after injection | -EX ↓ tumor volume by 34%. |
Daneryd, 1995 | 52 | Female Wistar Furth rats |
Leydig cell / 1.5mm3 injection of Leydig cell sarcoma (LTW) or Nitrosoguanine- induced adenocarcinoma s.c. into each flank |
Voluntary wheel running |
32d | Immediately after injection | - 13.4g vs 16.4g EX vs SED final LTW weights |
Zhu, 2008 | 42 | 21d old female Sprague-Dawley rats |
Mammary / 25 or 50 mg/kg MNU, i.p. |
Voluntary wheel running |
Voluntary wheel running for 8w | 1w post-injection | -Tumor weight 0.62g vs. 1.16g (SED vs. EX) |
Jones, 2010 | 57 | 3–4w old female athymic mice |
Mammary / 1×106 MDA-MB-231 cells, injected orthotopically |
Voluntary wheel running |
Voluntary wheel running for 41– 48d |
2d post-implant | No change in primary tumor growth (EX ↑21%) |
Yan, 2011 | 64 | 3w old male C57BL/6 mice |
Lung / 2.5×105/50 µl/mouse Lewis lung carcinoma cells s.c. lower dorsal region |
Voluntary wheel running |
Primary tumors excised at 1cm diameter, access to wheels continued for additional 2w. |
9w before tumor implantation | -No difference in tumor cross-sectional area and tumor volume. |
Jones, 2012 | 55 | 6–8w old male C57BL/6 mice |
Prostate / 5×105 mouse prostate C-1 cells, orthotopically |
Voluntary wheel running |
Wheel running for 8 weeks | 14d after tumor transplant | -Primary tumor growth was comparable between groups |
Goh, 2014 | 66 | 18m old Balb/cBy mice |
Mammary / 1×104 cells in 4th mammary fat pad |
Voluntary wheel running |
Voluntary wheel running for 90 days |
60 days prior to tumor transplant, followed by 30 days post-transplant |
-Inverse relationship between distance run and final tumor mass |
Betof, 2015 | 65 | Female Balb/c or female C57Bl/6 mice |
Mammary / 5×105 4T1-luc or 2.5×105 E0771 cells in dorsal mammary fat pad |
Voluntary wheel running |
Voluntary wheel running beginning either 9 weeks prior to tumor transplant, or at the time of tumor transplant |
SS: SED before and after transplant RS: EX for 9 weeks prior to transplant; SED after transplant SR: SED before transplant; EX after transplant RR: EX 9 weeks prior to transplant, continuing after transplant |
- Growth rates of SS and RS were similar, and growth rates of SR and RR were similar - EX slowed tumor growth compared to SED (both tumor models) |
Alessio, 2009 | 24 | 3w old female Sprague-Dawley rats |
Spontaneous tumors | Voluntary wheel running or activity box |
Wheel: every other day, 24h access throughout animals’ life. Activity box (PA): 1h in large activity box twice a week for life. |
Spontaneous tumors, animals followed for life. |
- EX ↓tumor growth rate |
Colbert, 2009 | 26 | Female heterozygous (p53+/−): MMTV-Wnt-1 transgenic mice |
Mammary / Transgenic |
Voluntary wheel running and forced treadmill running |
Treadmill running: TREX 1: 5×|45min|20m/min at 5% grade|until completion TREX 2: 5×|45min|24m/min at 5% grade|until completion Voluntary wheel running with 24 hour access. |
11w of age | - Time to tumor size of 1.5cm: 24.8d, 13.8d, and 19.5d in control, TREX1 and TREX2 animals. - Treadmill running led to faster tumor growth, no difference due to voluntary wheel running - Treadmill running ↓ survival |
Newton, 1965 | 60 | 45d old Sprague- Dawley rats |
Carcinoma / Equal volumes of Walker- 256 cells s.c. into the right flank. |
Forced treadmill running |
Pre-Tumor: 50h over 5d at 950ft/hr. Post-Tumor: 138h over 10d at 950 ft/hr. |
5d before tumor implantation +/− 4d after tumor implantation |
-EX ↓ final tumor weight vs SED control. -Early life manipulation + EX ↓ final tumor weight vs EX alone and SED. |
Uhlenbruck, 1991 |
63 | BALB/c mice | Sarcoma / 2.4×104 L- 1 cells s.c. |
Forced treadmill running |
7×|distances of 200m/400m/800m|0.3m/s|2w |
4w before and 2w after injection | -200m group ↓ tumor weight |
Woods, 1994 | 40 | 6w old male C3H/HeN mice |
Mammary / 2.5 ×105 mammary SCA-1 cells s.c. in the back. |
Forced treadmill running |
Treadmill running: Moderate: 7×|30min|18m/min at 5% grade|1w. Exhaustive: 7×|varied|18m/min for 30min, then 3m/min↑ every 30min until exhausted|1w |
3d prior to injection. | No difference in growth rate of tumor size at time of euthanasia (two weels) |
Whittal-Strange, 1998 |
39 | 21d old female Sprague-Dawley rats |
Mammary / 37.5mg/kg NMU i.p. at 50d of age, (1 day after last bout of EX) |
Forced treadmill running |
Progressive training to 5×|60min|18 m/min at 15% grade|4w |
21d of age (29d prior to injection) | -Tumor growth rate at 22w post-NMU: 0.043g/day in SED vs. 0.107g/day in EX -Final tumor weight: (3.2g in SED vs. 1.2g in EX |
Bacurau, 2000 | 49 | 12w old male Wistar rats |
Carcinoma / 2×107 Walker-256 cells s.c. in the flank |
Forced treadmill running |
5×|60min|60% of VO2 peak|10w | 8w prior to injection | -Day 15 tumor weight 1.82% vs 19% of BW (EX vs SED) -EX prolonged survival by 1.9 fold |
Westerlind, 2003 |
37 | 21d old female Sprague-Dawley rats |
Mammary / 25 or 50 mg/kg MNU, i.p. |
Forced treadmill running |
Week 1: 5×|10–15min|30m/min|1w. Week 2–9: 5×|30min|23– 25m/min|8w |
1w post-injection | -↑ Latency in EX (35.8d vs. 33.1d). -No difference in median tumor-free survival time was observed in the EX versus sham-EX (SHAM), nor were there any differences in multiplicity at either a high or moderate dose of MNU |
Zielinski, 2004 | 44 | 6–8w old female BALB/c mice |
Neoplastic lymphoid cells / 2×107 EL-4 cells s.c. in the back behind the neck |
Forced treadmill running |
7×|3h or until volitional fatigue|gradually increasing speed, 20–40m/min, 5% grade|5–14d |
First session immediately before injection. |
-No difference in tumor density |
Jones, 2005 | 56 | 3–4w old female athymic mice |
Mammary / Flank injection of 5×106 MDA-MB-231 cells |
Forced treadmill running |
5d/w|10m/min for 10min up to 18m/min for 45 min|0% grade|8w |
14d post-injection | -No change in tumor growth. |
Bacurau, 2007 | 48 | 8w old male Wistar rats |
Carcinoma / 2×107 Walker-256 cells s.c. in the flank |
Forced treadmill running |
5×|30min|85% of VO2 max|10w | 8w prior to injection | -Survival: 16d for SED, 45d for EX -EX tumors were 6.9% of final body mass vs. 17.33% for SED control. |
Lira, 2008 | 58 | Male Wistar rats | Carcinoma / 2×107 Walker-256 cells s.c. in the flank |
Forced treadmill running |
5×|60min|60–65% of VO2 peak|10w 2w pre-training period: rats ran progressively from 15 to 60min at 10m/min. Running was increased to 20m/min for two weeks after injection. |
8w prior to injection | -Tumor weight: 17.2g in SED; 1.9g in EX |
Murphy, 2011 | 59 | 4w old C3(1)SV40Tag mice |
Mammary / Transgenic (tumors began developing at 12w of age). |
Forced treadmill running |
6×|60m|20m/min at 5%|20w | 4w of age | -Tumor volume: ↓ in EX at 21 and 22w. |
Gueritat, 2014 | 69 | 10–12w old Copenhagen rats |
Prostate / surgical s.c. implantation of R3327 Dunning AT1 tumor fragment |
Forced treadmill running |
5×|15–60m|20–25 m/min|5w | 15d after tumor implantation | - EX rats had smaller tumors at 14 and 21 days compared to SED controls - Tumor doubling time was significantly slower in EX vs. SED (6.19d vs. 8.81d) |
Shalamzari, 2014 |
67 | 4–6w old Balb/c mice |
Mammary / 1×106 MC4-L2 s.c. in the flank |
Forced treadmill running |
-|20–40min|6–20 m/min|15w | RTR: Sedentary before and after transplant RTE: EX after tumor transplant only ETR: EX before tumor transplant only ETE: EX before and after transplant 9w before tumor transplant, and/or 6w after transplant |
- ETE had significantly slower growth compared to RTR - No difference in final tumor volume of RTE and ETR groups |
Aveseh, 2015 | 68 | 5w old female Balb/c mice |
Mammary / 1.2×106 MC4-L2 cells in right dorsal mammary fat pad |
Forced treadmill running |
7×|20–55min|10–20 m/min|7w | 10d after tumor transplant | -EX decreased tumor volume |
Malicka, 2015 | 45 | 4w old female Sprague Dawley rats |
Mammary / 180 mg/kg MNU i.p. |
Forced treadmill running |
Low intensity (LIT): 5×|10– 35min|0.48–1.34 km/h|12w Moderate intensity (MIT): 5×|10– 35min|0.6–1.68 km/h|12w High intensity (HIT): 5×|10– 35min|0.72–2.0 km/h|12w |
Immediately after MNU injection | -No difference in final volume of total tumor volume |
Piguet, 2015 | 46 | 7–9w old male AlbCrePten flox/flox mice |
Hepatocellular carcinoma / Transgenic |
Forced treadmill running |
5w acclimation period followed by: 5×|60m|12.5m/min|27w |
7–9w of age | -EX decreased total volume of liver tumors |
Hoffman, 1962 | 54 | Wistar rats | Carcinoma / 2mL Walker 256 cell suspension s.c. into the right thigh. |
Continuous running on a 20ft runway + swimming + revolving drum |
21d of EX, all EX did all 3 modalities each day: Runway: continuous running on 20ft runway, duration and intensity not clear Swimming: increasing 20min/day to 4h/day Revolving drum: 5.4 mi in 12h |
Immediately after injection | -97% inhibition of tumor growth. -Tumor weight ↓ in EX group |
Gershbein, 1974 | 53 | Holtzman rats | Carcinosarcoma / Walker-256 tumor i.m. into both hindlimbs. |
Forced swimming | 10×|15min|--|10d | Immediately after injection. | -EX ↓ tumor size. -No change in survival rates. |
Baracos, 1989 | 50 | Sprague-Dawley rats |
Hepatoma / 20uL Morris hepatoma 777 s.c. |
Forced swimming | Low: 5×|5min/d, increased by 5min/d for 3w. Medium: 5×|10min/d, increased by 10min/d for 3w. High: 5×|15min/d, increased by 15min/d for 3w. |
2 Groups - 3w of swimming, tumor transplant, then 3w additional swimming. -3w of swimming beginning 3d post-transplant |
-EX ↓ final tumor weight, both groups. |
Radak, 2002 | 61 | Adult female hybrid BDF1 mice |
Solid leukemia / 5×106 P-388 lymphoid leukemia cells s.c. |
Forced swimming | 5×|60min|--|10w ET: training terminated at tumor implantation. EC: training continued for 18d after tumor implantation. |
10w before injection. | -EC animals had slower tumor growth than ET and control, (endpoints were ~1.24cm3 vs. 2cm3 and 2.4cm3) |
SáezMdel, 2007 | 34 | 50d old female Sprague-Dawley rats |
Mammary / 5mg/w DMBA gastric intubation for 4w |
Forced swimming | 30m/d, 5d/w for 38–65d. | 1d after appearance of first tumor | -EX ↑ tumor growth by 200%. |
Almeida, 2009 | 47 | 7w old male Swiss mice |
Carcinoma / 2×106 Ehrlich tumor cells s.c. in the dorsum. |
Forced swimming | 5×|60min|50/80% max test|6w. Progressive load test began after 1w: load increased by 2% BW every 3min until exhaustion. |
4w before injection | -50% workload ↓ tumor weight and tumor volume (0.18mg/g and 0.11mm3) vs control (0.55mg/g and 0.48mm3) -Tumor volume and weight were 270% and 280% ↑ in SED mice. |
Sasvari, 2011 | 62 | Adult female BDF1 mice |
Sarcoma / 5×106 S- 180 cells s.c. injected. |
Forced swimming | 5×|60m|--|10w ETT: cells injected after EX. ETC: EX (10w), cells injected, EX (18 additional days) |
10w before tumor implantation. | -ETC ↓ final tumor weight vs. SED control. |
EX = exercise or activity groups; SED = Sedentary controls; NMU = nitrosomethylurea; MNU= 1-methyl-1-nitrosourea; AOM= azoxymethane; DMBA= 7,12-dimethylbenz(a)anthracene; DMH= 1,2-dimethylhydrazine; 3’-Me-DAB= 3’-methyl-4-dimethylaminoazobenzene; Fe-NTA= ferric nitrilotriacetate; s.c.= sub-cutaneous; i.v.= intravenous